Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New type of vaccine against nicotine addiction developed by TSRI scientists

21.05.2003


Scientists at The Scripps Research Institute (TSRI) have designed a new way to make vaccines against drugs of abuse that could become a valuable tool for treating addiction by helping the body clear the drug from the bloodstream.



The latest vaccine they created using this approach induces the body to clear nicotine.

"These new vaccines greatly suppress the reinforcing aspects of the drug," says principal investigator Kim D. Janda, Ph.D. "Blocking it before it gets to the brain--that’s the key."


The structure and design of the nicotine vaccine are described in an article that will be published in an upcoming issue of the Journal of the American Chemical Society. Research Associate Michael M. Meijler, Ph.D., who is the article’s lead author, synthesized this vaccine under the guidance of Janda, who holds the Ely R. Callaway, Jr. Chair in Chemistry and is an investigator in The Skaggs Institute for Chemical Biology at TSRI.

Having shown the vaccine’s effectiveness in laboratory models, Meijler and Janda have now reformulated the vaccine for investigation for use in human trials. Eventually, this sort of vaccine would be given to people undergoing smoking cessation programs to aid in their recovery.

Many believe that people continue to smoke because tobacco contains nicotine, which is an addictive chemical. Many smoking cessation strategies, in fact, provide cigarette addicts with nicotine from sources other than tobacco--such as patches or gum.

Janda and his laboratory, however, have taken an "immunopharmacotherapy" approach. That is, they have designed a drug that stimulates the immune system to clear the nicotine from the system. They based this work on previous successes Janda had in developing a vaccine for another addictive drug--cocaine--which is currently in clinical trials.

The new idea that they have developed is to take a chemical that resembles nicotine and use it to induce an active immune response. In this immune response, the body produces antibodies against nicotine that can neutralize it in the bloodstream. If a smoker later smokes a cigarette, the antibodies will clear the nicotine from the system before it reaches the brain.

Developing a nicotine vaccine proved difficult. At first, Janda and his colleagues were not able to induce an effective immune response as they had previously with cocaine. Then Janda and Meijler realized that the difference could be that cocaine is a relatively inflexible molecule where nicotine has a flexible axis that allows it to adopt multiple shapes.

Janda and Meijler had been designing a vaccine that was equally flexible, and so they decided to make one that was rigid and resembled only one form of nicotine.

"These [induced] antibodies make a much more focused immune response," says Meijler. In fact, he adds, the vaccine is better because it induced a larger antibody response and the antibodies themselves bound more tightly (with higher affinity) to the nicotine.

Furthermore, adds Janda, "This could be a general method for vaccine development for drugs of abuse--period."

The research article "A New Strategy for Improved Vaccines Using Conformationally Constrained Haptens" is authored by Michael M. Meijler, Masayuki Matsushita, Lawrence J. Altobell, III, Peter Wirsching, and Kim D. Janda and will appear in the June 18, 2003 issue of the Journal of the American Chemical Society. The research was funded by The Skaggs Institute for Research.

Supporting Material: Statistics on Smoking and Public Health
Smoking is a major health problem in the United States, and hundreds of thousands of Americans die each year from smoking-related lung cancer, ischemic heart disease, and chronic airway obstruction.

Although the percentage of U.S. residents who smoke has declined steadily in the United States since the mid-1960s, about 22.8 percent of the total adult population still smokes, according to the U.S. Centers for Disease Control and Prevention (CDC). San Diego and Orange County are two of the five metropolitan areas with the nation’s lowest smoking rates. The San Diego regional rate was 15.2 percent.

Nevertheless, smoking-related cancer is still a great cause for concern in Southern California and in the rest of the nation. In a 2002 report, the CDC estimated that from 1995 to 1999, smoking killed more than 440,000 people in the United States each year and caused more than $150 billion in annual health-related economic losses.



For supporting statistics on tobacco use and related mortality, please see: A 2001 report from the CDC: "Cigarette Smoking in 99 Metropolitan Areas--United States, 2000," MMWR 50(49); December 14, 2001. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5049a3.htm.

A 2002 report from the CDC: "Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Economic Costs--United States, 19951999," MMWR 51(14) April 12, 2002. http://www.cdc.gov/tobacco/research_data/economics/mmwr5114.highlights.htm.

Jason Bardi | EurekAlert!
Further information:
http://www.scripps.edu/
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5049a3.htm
http://www.cdc.gov/tobacco/research_data/economics/mmwr5114.highlights.htm

More articles from Health and Medicine:

nachricht Correct antibiotic dosing could preserve lung microbial diversity in cystic fibrosis
22.02.2019 | Children's National Health System

nachricht Researchers find trigger that turns strep infections into flesh-eating disease
19.02.2019 | Houston Methodist

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: (Re)solving the jet/cocoon riddle of a gravitational wave event

An international research team including astronomers from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has combined radio telescopes from five continents to prove the existence of a narrow stream of material, a so-called jet, emerging from the only gravitational wave event involving two neutron stars observed so far. With its high sensitivity and excellent performance, the 100-m radio telescope in Effelsberg played an important role in the observations.

In August 2017, two neutron stars were observed colliding, producing gravitational waves that were detected by the American LIGO and European Virgo detectors....

Im Focus: Light from a roll – hybrid OLED creates innovative and functional luminous surfaces

Up to now, OLEDs have been used exclusively as a novel lighting technology for use in luminaires and lamps. However, flexible organic technology can offer much more: as an active lighting surface, it can be combined with a wide variety of materials, not just to modify but to revolutionize the functionality and design of countless existing products. To exemplify this, the Fraunhofer FEP together with the company EMDE development of light GmbH will be presenting hybrid flexible OLEDs integrated into textile designs within the EU-funded project PI-SCALE for the first time at LOPEC (March 19-21, 2019 in Munich, Germany) as examples of some of the many possible applications.

The Fraunhofer FEP, a provider of research and development services in the field of organic electronics, has long been involved in the development of...

Im Focus: Regensburg physicists watch electron transfer in a single molecule

For the first time, an international team of scientists based in Regensburg, Germany, has recorded the orbitals of single molecules in different charge states in a novel type of microscopy. The research findings are published under the title “Mapping orbital changes upon electron transfer with tunneling microscopy on insulators” in the prestigious journal “Nature”.

The building blocks of matter surrounding us are atoms and molecules. The properties of that matter, however, are often not set by these building blocks...

Im Focus: University of Konstanz gains new insights into the recent development of the human immune system

Scientists at the University of Konstanz identify fierce competition between the human immune system and bacterial pathogens

Cell biologists from the University of Konstanz shed light on a recent evolutionary process in the human immune system and publish their findings in the...

Im Focus: Transformation through Light

Laser physicists have taken snapshots of carbon molecules C₆₀ showing how they transform in intense infrared light

When carbon molecules C₆₀ are exposed to an intense infrared light, they change their ball-like structure to a more elongated version. This has now been...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Global Legal Hackathon at HAW Hamburg

11.02.2019 | Event News

The world of quantum chemistry meets in Heidelberg

30.01.2019 | Event News

Our digital society in 2040

16.01.2019 | Event News

 
Latest News

JILA researchers make coldest quantum gas of molecules

22.02.2019 | Physics and Astronomy

Understanding high efficiency of deep ultraviolet LEDs

22.02.2019 | Materials Sciences

Russian scientists show changes in the erythrocyte nanostructure under stress

22.02.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>